- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Fibroblast growth factor 21 (FGF21) is a secreted endocrine signaling protein involved in regulation of glucose metabolism, lipid utilization, energy expenditure, and adaptive metabolic homeostasis. The FGF21 Antibody / Metabolic Signaling Hormone Antibody clone FGF21/4343 is designed for highly selective detection of FGF21 expression in studies involving metabolic signaling, hepatokine biology, endocrine regulation, and energy balance-associated pathways.
FGF21 is encoded by the FGF21 gene on chromosome 19q13 and belongs to the endocrine subgroup of fibroblast growth factors. Unlike many canonical FGFs that primarily function through paracrine signaling, FGF21 circulates systemically as a hormone-like metabolic regulator. The protein is produced predominantly by hepatocytes but is also expressed in adipose tissue, pancreas, skeletal muscle, and additional metabolically active tissues under specific physiologic conditions.
FGF21 signaling is closely associated with fasting adaptation, ketogenesis, lipid oxidation, and insulin sensitivity. Expression of FGF21 may increase during metabolic stress states including starvation, mitochondrial dysfunction, obesity-associated metabolic imbalance, and endoplasmic reticulum stress. Through interactions with fibroblast growth factor receptors and the co-receptor beta-Klotho, FGF21 regulates transcriptional and metabolic programs involved in nutrient sensing and energy utilization.
The biologic importance of FGF21 has generated substantial interest across obesity research, diabetes biology, fatty liver disease studies, and metabolic syndrome-associated signaling pathways. Altered circulating FGF21 levels have been associated with insulin resistance, hepatic steatosis, cardiovascular disease, and adaptive metabolic stress responses. The protein has therefore emerged as both a metabolic biomarker candidate and a therapeutic target within endocrine and metabolic disease research.
The clone FGF21/4343 monoclonal antibody is further differentiated by protein microarray specificity validation performed against a HuProt(TM) array containing more than 19,000 full-length human proteins. This large-scale specificity screening approach helps evaluate potential cross-reactivity across the human proteome and is particularly valuable for secreted growth factor targets that share conserved structural domains within larger cytokine and fibroblast growth factor families. The resulting specificity profile supports selective detection of FGF21 in studies where target specificity and reduced off-target recognition are important experimental considerations.
Immunohistochemical analysis using FGF21 antibodies commonly demonstrates cytoplasmic staining patterns within metabolically active epithelial and hepatocyte-associated tissue compartments, consistent with the role of FGF21 as a secreted endocrine metabolic regulator. FGF21 continues to serve as an important target in studies involving metabolic adaptation, endocrine signaling, nutrient sensing, obesity biology, and systemic energy homeostasis.
Additional antibodies involved in metabolic adaptation, endocrine signaling, hepatokine biology, and energy homeostasis can be explored within our Metabolism Antibodies collection.
Optimal dilution of the FGF21 Antibody / Metabolic Signaling Hormone Antibody should be determined by the researcher.
A portion of amino acids 91-209 was used as the immunogen for the Fibroblast Growth Factor 21 antibody.
Aliquot the Fibroblast Growth Factor 21 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
FGF21 antibody, Fibroblast growth factor 21 antibody, Metabolic hormone antibody, Hepatokine antibody, Endocrine metabolism regulator antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.